Health-related quality of life (HRQoL) with pembrolizumab (pembro) in resected high-risk stage II melanoma in the phase 3 KEYNOTE-716 study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...

Automation, including the use of artificial intelligence, has been identified as a possible opportunity to help reduce the gap in access and quality for radiotherapy and other aspects of cancer care.

Aga Khan University Hospital bets in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced ...

For the first time, the Uganda Cancer Institute in Kampala has treated an aggressive paediatric brain tumour using an advanced radiotherapy known as volumetric modulated arc therapy, with support from ...